What is SPHRY's gross margin?

Starpharma (SPHRY) has a gross margin of 29% and a net margin of -725%.

What is SPHRY's P/E ratio?

Track Starpharma (SPHRY) P/E ratio, ROE, and valuation metrics over time.

Where can I see SPHRY's full financials?

See Starpharma (SPHRY) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Starpharma (SPHRY) Financials — Revenue, Earnings, Cash Flow

Also trades as: SPL.AX (ASX) · $vol 1M · SPHRF (OTC) · $vol 0M

$5.05

-0.80 (-13.68%)

Weekly Expected Move ±13.3%

$4 $4 $5 $6 $6

OTC · Healthcare · Biotechnology · Tech Score Buy · Power 68 · $212.6M mcap · 29M float · 0.0034% daily turnover · Short 57% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$16M

Revenue

+34.9% YoY

$-15M

Net Income

+35.7% YoY

$-7M

Free Cash Flow

+67.9% YoY

29.1%

Gross Margin

-1258.0%

Op. Margin

-725.1%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-73.1%

ROA-54.8%

ROIC-826.0%

Valuation

P/E-46.8

P/B25.1

EV/EBITDA0.0

Leverage

Debt/Equity0.05

Current Ratio3.40

Interest Cov.0.0x

Quality Scores

Piotroski F5/9

Altman Z—

Beneish M-9.47